Ranbaxy’s subsidiary launches esomeprazole in UK
05 Sep 2011
1
Ranbaxy Laboratories Ltd said its UK's wholly-owned subsidiary Ranbaxy (UK) Ltd. had successfully launched esomeprazole 20mg and 40mg tablets.
Esomeprazole is the first approved generic bio-equivalent version of AstraZeneca's prescription drug Nexium in the UK, with an annual sale of £60 million, as per IMS June 2011 data.
Esomeprazole is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (FORD/GERD) and Zollinger-Ellison syndrome, the company said with its filing with the Bombay Stock Exchange.
The company said the product would be offered through pharmacies, retail and wholesale stores with immediate effect.
.webp)
